Current progress of chimeric antigen receptor (CAR) T versus CAR NK cell for immunotherapy of solid tumors

A Esmaeilzadeh, K Hadiloo, M Jabbari, R Elahi - Life Sciences, 2023 - Elsevier
Equipping cancer-fighting immune cells with chimeric antigen receptor (CAR) has gained
immense attention for cancer treatment. CAR-engineered T cells (CAR T cells) are the first …
被引用次数：7 相关文章

Current progress of chimeric antigen receptor (CAR) T versus CAR NK cell for immunotherapy of solid tumors.

A Esmaeilzadeh, K Hadiloo, M Jabbari, R Elahi - Life Sciences, 2023 - europepmc.org
Equipping cancer-fighting immune cells with chimeric antigen receptor (CAR) has gained
immense attention for cancer treatment. CAR-engineered T cells (CAR T cells) are the first …

Current progress of chimeric antigen receptor (CAR) T versus CAR NK cell for immunotherapy of solid tumors

A Esmaeilzadeh, K Hadiloo, M Jabbari, R Elahi - Life sciences - pubmed.ncbi.nlm.nih.gov
Equipping cancer-fighting immune cells with chimeric antigen receptor (CAR) has gained
immense attention for cancer treatment. CAR-engineered T cells (CAR T cells) are the first …